Back to today’s briefing

Story perspectives

McDonald's Downgraded Amid Declining Sales and Weight-Loss Drug Impact

6/11/2025

44 8

Summary

Story summary

McDonald's faced a significant blow as Redburn Atlantic downgraded its rating from buy to sell, citing dwindling customer traffic influenced by the rise of weight-loss drugs from Eli Lilly and Novo Nordisk. This shift left McDonald's struggling, marking it as the poorest performer in premarket trading among the Dow Jones Industrial Average on Tuesday.

1 of 1

Story summary

McDonald's faced a significant blow as Redburn Atlantic downgraded its rating from buy to sell, citing dwindling customer traffic influenced by the rise of weight-loss drugs from Eli Lilly and Novo Nordisk. This shift left McDonald's struggling, marking it as the poorest performer in premarket trading among the Dow Jones Industrial Average on Tuesday.